Clinical Trial Update: Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating growth hormone to prevent short stature in young girls with Turner syndrome; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• Growth hormone treatment (growth hormone)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Turner's Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2018-12-14